{"schema_version":"secwatch.filing_event.v1","accession":"0001040130-24-000114","form_type":"8-K","ticker":"PETS","cik":"0001040130","company_name":"PETMED EXPRESS INC","filed_at":"2024-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.459198+00:00","generated_at":"2026-05-30T04:15:37.218820+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"PetMed Express Q2 FY2025: net sales $59.6M, net income $2.3M, EPS $0.11","bullets":["Net sales of $59.6M; net income $2.3M ($0.11 diluted EPS) vs $0.7M ($0.03) in prior year.","Gross margin 29.1% (+0.8% YoY); Adjusted EBITDA $2.1M, sequential improvement from $(1.5)M in Q1.","CEO cites cost savings from consolidating PetMeds/PetCareRx ops; positioned for growth initiatives."],"urls":{"canonical":"https://secwatch.observer/filing/0001040130-24-000114","json":"https://secwatch.observer/filing/0001040130-24-000114.json","markdown":"https://secwatch.observer/filing/0001040130-24-000114.md","text":"https://secwatch.observer/filing/0001040130-24-000114.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1040130/000104013024000114/0001040130-24-000114-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1040130/000104013024000114/pets-20241106.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T04:15:37.218820+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}